ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.676,41
1,61%
S&P 500
5.599,30
0,49%
Dow Jones
41.350,93
-0,20%
Euro vs US Dollar
1,08877
0,02%
Bitcoin
83.314,41
-0,44%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. AbCellera Biologics Inc (ABCL) Börsenkurse

AbCellera Biologics Inc

AbCellera Biologics Inc (ABCL)

NASDAQ
2,35
0,12
(5,38%)
Geschlossen 13 März 9:00PM
Verzögert um 15 Minuten
2,38
0,03
(1,28%)
Nach Börsenschluss: 12:55AM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
2,38
Gebot
2,36
Fragen
2,40
Volumen
2.713.462
2,26 Tagesbereich 2,36
2,11 52-Wochen-Bereich 4,99
Marktkapitalisierung
701,304M
Handelsende
2,23
Handelsbeginn
2,30
Letzte Trade
200
@
2.38
(formt)
Letzter Handelszeitpunkt
Finanzvolumen
US$ 6.256.904
VWAP
2,3059
Durchschnittliches Volumen (3 Mio.)
3.980.666
Ausgegebene Aktien
294.665.532
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,73
Gewinn pro Aktie (EPS)
-0,5
Erlöse
38,03M
Nettogewinn
-146,4M

Über AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Sektor
Medicinal Chems,botanicl Pds
Branche
Medicinal Chems,botanicl Pds
Website
www.abcellera.com
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
AbCellera Biologics Inc is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker ABCL. The last closing price for AbCellera Biologics was US$2,23. Over the last year, AbCellera Biologics shares have traded in a share price range of US$ 2,11 to US$ 4,99.

AbCellera Biologics currently has 294.665.532 shares in issue. The market capitalisation of AbCellera Biologics is US$657,10 million. AbCellera Biologics has a price to earnings ratio (PE ratio) of -4.73.

ABCL Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
11 März 2025
ABCL (5,38%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
10 März 2025
ABCL (5,38%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
07 März 2025
ABCL (5,38%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
27 Februar 2025
ABCL (5,38%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
27 Februar 2025
ABCL (5,38%)

Form 8-K - Current report
Edgar (US Regulatory)
27 Februar 2025
ABCL (5,38%)

Form 8-K - Current report
Edgar (US Regulatory)
18 Februar 2025
ABCL (5,38%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.062.586206896552.322.43432.1149159932.29604559CS
4-0.52-17.93103448282.93.62.1149538332.78915155CS
12-0.46-16.19718309862.843.682.1139806662.96992837CS
26-0.35-12.82051282052.733.682.1129766312.89468075CS
52-2.59-52.11267605634.974.992.1122561773.04138054CS
156-5.61-70.21276595747.9914.972.1120935586.31467204CS
260-58.62-96.09836065576171.912.11199919110.10767264CS

ABCL - Frequently Asked Questions (FAQ)

What is the current AbCellera Biologics share price?
The current share price of AbCellera Biologics is US$ 2,38
How many AbCellera Biologics shares are in issue?
AbCellera Biologics has 294.665.532 shares in issue
What is the market cap of AbCellera Biologics?
The market capitalisation of AbCellera Biologics is USD 657,1M
What is the 1 year trading range for AbCellera Biologics share price?
AbCellera Biologics has traded in the range of US$ 2,11 to US$ 4,99 during the past year
What is the PE ratio of AbCellera Biologics?
The price to earnings ratio of AbCellera Biologics is -4,73
What is the cash to sales ratio of AbCellera Biologics?
The cash to sales ratio of AbCellera Biologics is 18,22
What is the reporting currency for AbCellera Biologics?
AbCellera Biologics reports financial results in USD
What is the latest annual turnover for AbCellera Biologics?
The latest annual turnover of AbCellera Biologics is USD 38,03M
What is the latest annual profit for AbCellera Biologics?
The latest annual profit of AbCellera Biologics is USD -146,4M
What is the registered address of AbCellera Biologics?
The registered address for AbCellera Biologics is 2215 YUKON STREET, VANCOUVER, BRITISH COLUMBIA, V5Y 0A1
What is the AbCellera Biologics website address?
The website address for AbCellera Biologics is www.abcellera.com
Which industry sector does AbCellera Biologics operate in?
AbCellera Biologics operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CRVOCervoMed Inc
US$ 6,15
(160,59%)
154M
ZENAZenaTech Inc
US$ 4,5505
(61,94%)
6,88M
OPRXOptimizeRx Corporation
US$ 6,265
(51,33%)
13,1M
SSPEW Scripps Company
US$ 2,05
(43,36%)
16,99M
GRPNGroupon Inc
US$ 13,9807
(43,10%)
10,42M
HITHealth In Tech Inc
US$ 1,32
(-82,31%)
16,78M
SPHLSpringview Holdings Ltd
US$ 1,24
(-79,33%)
11,08M
APDNApplied DNA Sciences Inc
US$ 0,0619
(-57,89%)
36,75M
ZYXIZynex Inc
US$ 3,39
(-51,57%)
4,05M
HEPAHepion Pharmaceuticals Inc
US$ 0,0488
(-41,90%)
81,09M
STISolidion Technology Inc
US$ 0,174899
(38,70%)
506,61M
NVDANVIDIA Corporation
US$ 115,74
(6,42%)
298,41M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,1432
(15,59%)
202,29M
VSTEVast Renewable Ltd
US$ 0,6182
(23,66%)
184,27M
CRVOCervoMed Inc
US$ 6,15
(160,59%)
154M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
ABCL
AbCellera Biologics
BIT
UC3F94
Unicredit Bank
TSXV
AQS.DB
Aequus Pharmaceuticals
TSXV
WAM
Western Alaska Minerals
AMEX
IDGT
iShares US Digital Infra...
COIN
SAXUSD
SOLA-X
NASDAQ
ZVSA
ZyVersa Therapeutics
BIT
UC3XA3
Unicredit Bank
BITI
IT2700
Ftse Italia Beni e Servizi Indus
COIN
QRLGBP
Quantum Resistant Ledger
NYSE
DASH
DoorDash
USOTC
YTENQ
Yield10 Bioscience (CE)
ASX
NDO
Nido Education
BIT
F38407
Vontobel Financial Produ...
CSE
IEQ
IntellaEquity
USOTC
BTTC
Bitech Technologies (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten